Denise B Pecht, MD | |
575 Professional Dr, Ste 580, Lawrenceville, GA 30045-3333 | |
(770) 339-4000 | |
(770) 339-9037 |
Full Name | Denise B Pecht |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 38 Years |
Location | 575 Professional Dr, Lawrenceville, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043204498 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | 034436 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northside Hospital Gwinnett | Lawrenceville, GA | Hospital |
Eastside Medical Center | Snellville, GA | Hospital |
Northside Hospital | Atlanta, GA | Hospital |
Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Woman Care Llc | 5395807218 | 503 |
News Archive
The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.
New data confirm that subcutaneous injection of the innovative new anti-anemia agent CERA (Continuous Erythropoietin Receptor Activator) delivers rapid, sustained and stable correction of anemia in a broad spectrum of patients with chronic kidney disease at dosing intervals of up to 4 weeks.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
KYTHERA Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application that claims synthetic deoxycholic acid or pharmaceutically acceptable salts thereof, including the synthetic form that is used in ATX-101, a potential first-in-class, injectable drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin."
› Verified 8 days ago
Entity Name | Unified Women's Care Of Georgia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578812012 PECOS PAC ID: 0244482297 Enrollment ID: O20121220000355 |
News Archive
The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.
New data confirm that subcutaneous injection of the innovative new anti-anemia agent CERA (Continuous Erythropoietin Receptor Activator) delivers rapid, sustained and stable correction of anemia in a broad spectrum of patients with chronic kidney disease at dosing intervals of up to 4 weeks.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
KYTHERA Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application that claims synthetic deoxycholic acid or pharmaceutically acceptable salts thereof, including the synthetic form that is used in ATX-101, a potential first-in-class, injectable drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin."
› Verified 8 days ago
Entity Name | Florida Woman Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386823243 PECOS PAC ID: 5395807218 Enrollment ID: O20220408002137 |
News Archive
The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.
New data confirm that subcutaneous injection of the innovative new anti-anemia agent CERA (Continuous Erythropoietin Receptor Activator) delivers rapid, sustained and stable correction of anemia in a broad spectrum of patients with chronic kidney disease at dosing intervals of up to 4 weeks.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
KYTHERA Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application that claims synthetic deoxycholic acid or pharmaceutically acceptable salts thereof, including the synthetic form that is used in ATX-101, a potential first-in-class, injectable drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Denise B Pecht, MD 575 Professional Dr, Ste 580, Lawrenceville, GA 30045-3333 Ph: (770) 339-4000 | Denise B Pecht, MD 575 Professional Dr, Ste 580, Lawrenceville, GA 30045-3333 Ph: (770) 339-4000 |
News Archive
The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.
New data confirm that subcutaneous injection of the innovative new anti-anemia agent CERA (Continuous Erythropoietin Receptor Activator) delivers rapid, sustained and stable correction of anemia in a broad spectrum of patients with chronic kidney disease at dosing intervals of up to 4 weeks.
Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.
KYTHERA Biopharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application that claims synthetic deoxycholic acid or pharmaceutically acceptable salts thereof, including the synthetic form that is used in ATX-101, a potential first-in-class, injectable drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin."
› Verified 8 days ago
Mrs. Pushpa Lalaji, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2878 Five Forks Trickum Rd, 2a, Lawrenceville, GA 30044 Phone: 678-344-8700 Fax: 678-344-8600 | |
Erica Jin, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1942 Atkinson Rd, Suite 100, Lawrenceville, GA 30043 Phone: 678-775-0600 Fax: 678-377-5284 | |
Dr. Joseph F Pohl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd., Suite 365, Lawrenceville, GA 30046 Phone: 770-962-0972 | |
Dr. Vandene Tamoy Miller-adams, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1942 Atkinson Rd Ste 100, Lawrenceville, GA 30043 Phone: 678-775-0600 Fax: 678-377-5284 | |
David P. Spielvogel, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1766 Crowes Lake Ct, Lawrenceville, GA 30043 Phone: 678-646-7545 | |
Laura Marie Morgigno, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 761 Old Norcross Rd, Lawrenceville, GA 30046 Phone: 770-513-4000 Fax: 770-995-1604 |